Martha Morrell sold $136k of NPCE
Chief Medical Officer at NeuroPace Inc. 13,402 shares at an average of $10.12, traded Dec 26, 2023, filed Dec 28, 2023.
Score components
- +15RoleOfficer
- +11Trade size$136k at market
- +5Share of holdings soldSold 11% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +45.7%, 3m +32.0%, 6m -30.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001209191-23-059946, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 26, 2023 | SOpen-market sale Common Stock10b5-1 | -102 | $10.00 | $1,020 | 123,327 | Dec 28, 2023 |
| Dec 27, 2023 | SOpen-market sale Common Stock10b5-1 | -13,300 | $10.12 | $135k | 110,027 | Dec 28, 2023 |
Related signals
Other insiders at NeuroPace Inc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 21Weak | NeuroPace Inc | Martha Morrell CHIEF MEDICAL OFFICER | $399k 25,000 shares | -33% | |
| 37Weak | NPCEsell NeuroPace Inc | Orbimed Advisors LLC owner | $2.7M 168,136 shares | -5% | |
| 57Moderate | NPCEsell NeuroPace Inc | Kck Ltd. owner | $50M 5,270,845 shares | -100% | |
| 37Weak | NPCEsell NeuroPace Inc | Kck Ltd. owner | $1.2M 224,138 shares | -4% | |
| 12Weak | NPCEsell NeuroPace Inc | Kck Ltd. owner | $25k 4,082 shares | -0% | |
| 19Weak | NPCEsell NeuroPace Inc | Kck Ltd. owner | $53k 8,598 shares | -0% | |
| 26Weak | NPCEsell NeuroPace Inc | Kck Ltd. owner | $303k 46,426 shares | -1% | |
| 25Weak | NPCEsell NeuroPace Inc | Kck Ltd. owner | $275k 39,684 shares | -1% | |
| 28Weak | NPCEsell NeuroPace Inc | Orbimed Advisors LLC owner | $409k 29,206 shares | -1% | |
| 17Weak | NPCEsell NeuroPace Inc | Orbimed Advisors LLC owner | $25k 1,781 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.